Regulatory approval has been granted for a novel device aimed at reducing the hospitalisation time of cancer patients. Named Liberty, this device empowers patients to conduct blood tests and share the results from the comfort of their homes, independently and without supervision. Advocates of Liberty highlight its potential to minimise the burden of frequent hospital visits on patients, while healthcare…
Ben KempMay 14, 2024